<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02122068</url>
  </required_header>
  <id_info>
    <org_study_id>CMIT003</org_study_id>
    <nct_id>NCT02122068</nct_id>
  </id_info>
  <brief_title>Meditation for Dementia Caregivers Major Depressive Disorder in Family Dementia Caregivers</brief_title>
  <official_title>Mentalizing Imagery Therapy for Major Depressive Disorder in Family Dementia Caregivers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Friends of Semel Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Morris A. Hazan Memorial Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of California, San Francisco</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Family dementia caregivers provide a needed service to relatives with dementia and to&#xD;
      society, but are often at risk for consequences to their own health such as depression,&#xD;
      reduced immune system function, and burnout. Mentalizing Imagery Therapy (MIT, previously&#xD;
      known as Central Meditation and Imagery Therapy) is a novel group mindfulness and guided&#xD;
      imagery intervention designed to help caregivers reduce depressive symptoms and cope with the&#xD;
      stress of caregiving. We will conduct a pilot feasibility of MIT versus home relaxation&#xD;
      practice with 24 dementia caregivers. Half of the caregivers will be randomly assigned to&#xD;
      receive a relaxation recording, while the other half will receive MIT.&#xD;
&#xD;
      To measure the effects of MIT, we will obtain depression symptom ratings and questionnaires&#xD;
      about psychological symptoms before and after MIT. We will also study the biological effects&#xD;
      of MIT. We will do so by measuring brain activity, recording the pulse in order to determine&#xD;
      variation in beat to beat intervals of the heart, and studying patterns of gene expression.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Actual">September 2015</completion_date>
  <primary_completion_date type="Actual">September 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hamilton Depression Rating Scale</measure>
    <time_frame>1 week post intervention (5 weeks)</time_frame>
    <description>17 item rating scale, range of scores 0-52, higher scores indicate worse outcome</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quick Inventory of Depression Symptoms - Self Report</measure>
    <time_frame>1 week post intervention (5 weeks)</time_frame>
    <description>16 item rating scale, range of scores 0-27, higher scores indicate worse outcome</description>
  </secondary_outcome>
  <other_outcome>
    <measure>State Trait Anxiety Inventory</measure>
    <time_frame>1 week post intervention (5 weeks)</time_frame>
    <description>20 item rating scale, scores range from 20 to 80, higher scores indicate worse outcome</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">26</enrollment>
  <condition>Mentalizing Imagery Therapy</condition>
  <condition>Relaxation Recording</condition>
  <arm_group>
    <arm_group_label>Mentalizing Imagery Therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Meditation and mindfulness 4 week program</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Relaxation cd</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Listening to a relaxation cd</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Mentalizing Imagery Therapy</intervention_name>
    <description>4 week long meditation and mindfulness intervention</description>
    <arm_group_label>Mentalizing Imagery Therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Relaxation cd</intervention_name>
    <arm_group_label>Relaxation cd</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Caregivers of relatives with dementia who present to the UCLA Alzheimer and Dementia&#xD;
             Care Program, or other UCLA geriatric or memory clinics for evaluation of dementia,&#xD;
             cognitive impairment and/or co-existing behavioral disturbances.&#xD;
&#xD;
          2. Caregivers will be identified by the family member with dementia or the physician as&#xD;
             the primary source of assistance and/or support&#xD;
&#xD;
          3. 45 years of age or older&#xD;
&#xD;
          4. Patient Health Questionnaire Score &gt; 9&#xD;
&#xD;
          5. In contact with the individual with dementia at least three times/week for no less&#xD;
             than one year, and a relative of the care-recipient (i.e., spouse or adult child).&#xD;
&#xD;
          6. Adequate written and oral fluency in English to understand and complete study forms&#xD;
             and converse with study personnel.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Current diagnosis of schizophrenia or any psychotic disorder including psychotic&#xD;
             depression, mania, alcohol or drug dependence, mental retardation, any pervasive&#xD;
             developmental disorder or cognitive disorder (according to DSM-IV) criteria.&#xD;
&#xD;
             2. Medically unstable, delirious, or terminally ill (e.g. medical illness requiring&#xD;
             hospitalization or intense outpatient management, such as heart disease; heart attack&#xD;
             in the past 6 months; congestive heart failure; severe heart arrythmias; unstable&#xD;
             hypertension; poorly controlled diabetes; or pending surgery).&#xD;
&#xD;
             3. Past history of skull fracture; cranial surgery entering the calvarium; space&#xD;
             occupying intracranial lesion; stroke/ aneurysm; Parkinson's or Huntington's disease;&#xD;
             or Multiple Sclerosis.&#xD;
&#xD;
             4. Participants regularly practicing (â‰¥ 2 times per week) any of the techniques&#xD;
             utilized in the study to reduce stress: meditation, guided imagery, yoga.&#xD;
&#xD;
             5. Active suicidal plan, or suicide attempt within the past month. 6. Excessive use of&#xD;
             alcohol, i.e., men whose alcohol consumption exceeds 14 standard drinks per week or 4&#xD;
             drinks per day, and women whose alcohol consumption exceeds 7 standard drinks per week&#xD;
             or 3 drinks per day.&#xD;
&#xD;
             7. Needing to adjust or change anti-depressant treatment, including medications,&#xD;
             psychotherapy, repetitive Transcranial Magnetic Stimulation (rTMS), Electroconvulsive&#xD;
             Therapy (ECT), or Vagus Nerve Stimulation (VNS).&#xD;
&#xD;
             8. Ideas of harm toward the care recipient, current violence, or an APS report on&#xD;
             file.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Felipe A Jain, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, Los Angeles</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of California, Los Angeles</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90095</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Jain FA, Nazarian N, Lavretsky H. Feasibility of central meditation and imagery therapy for dementia caregivers. Int J Geriatr Psychiatry. 2014 Aug;29(8):870-6. doi: 10.1002/gps.4076. Epub 2014 Jan 29.</citation>
    <PMID>24477920</PMID>
  </reference>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>April 16, 2014</study_first_submitted>
  <study_first_submitted_qc>April 22, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 24, 2014</study_first_posted>
  <last_update_submitted>January 19, 2021</last_update_submitted>
  <last_update_submitted_qc>January 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Meditation</keyword>
  <keyword>Mindfulness</keyword>
  <keyword>Caregiver</keyword>
  <keyword>Dementia</keyword>
  <keyword>Depression</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dementia</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Depressive Disorder, Major</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

